Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistSoul Vapor was cited for manufacturing and distributing e-liquid tobacco products without required premarket authorization from the FDA, in violation of the Family Smoking Prevention and Tobacco Control Act. The company's e-liquids, identified as newly deemed tobacco products under FDA jurisdiction as of August 8, 2016, were being offered for sale through the company website without obtaining the necessary marketing authorization order required under section 910 of the Federal Food, Drug, and Cosmetic Act. The products were determined to be adulterated and misbranded due to the lack of required premarket approval for these newly regulated tobacco products.